Xortx Therapeutics

Calgary, Canada

XORTX Therapeutics is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease

$5.0M raised

May 2026

Post-IPO Equity

Biopharma Biotechnology Pharmaceutical Therapeutics

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Xortx Therapeutics

How much funding has Xortx Therapeutics raised?

Xortx Therapeutics has raised $5.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2026.

Where is Xortx Therapeutics headquartered?

Xortx Therapeutics is headquartered in Calgary, Canada.

What does Xortx Therapeutics do?

XORTX Therapeutics is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease

What stage is Xortx Therapeutics at?

Xortx Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 14, 2026.

MLA

"Xortx Therapeutics — Funding & Investors." VCBacked, May 14, 2026, https://www.vcbacked.co/company/xortx-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2026). Xortx Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/xortx-therapeutics

Wikipedia (cite web)

{{cite web |title=Xortx Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/xortx-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 14, 2026.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.